Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 122241293 | 12224129 | 3 | F | 20160324 | 20160621 | 20160330 | 20160701 | PER | US-009507513-1603USA012548 | MERCK | 61.00 | YR | F | Y | 0.00000 | 20160701 | OT | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 122241293 | 12224129 | 1 | PS | BELSOMRA | SUVOREXANT | 1 | Oral | UNK | U | 204569 | TABLET | ||||||||
| 122241293 | 12224129 | 2 | SS | AMBIEN | ZOLPIDEM TARTRATE | 1 | U | 0 | |||||||||||
| 122241293 | 12224129 | 3 | C | LEXAPRO | ESCITALOPRAM OXALATE | 1 | U | 0 | |||||||||||
| 122241293 | 12224129 | 4 | C | STATIN (UNSPECIFIED) | UNSPECIFIED INGREDIENT | 1 | U | 0 | |||||||||||
| 122241293 | 12224129 | 5 | C | ASPIRIN. | ASPIRIN | 1 | U | 0 | TABLET |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 122241293 | 12224129 | 1 | Insomnia |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 122241293 | 12224129 | Drug ineffective | |
| 122241293 | 12224129 | Memory impairment |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 122241293 | 12224129 | 1 | 20160324 | 0 |